Latest News about BMY
Recent news which mentions BMY
Bristol Myers' Opdivo Plus Yervoy Combo Therapy Secures European Approval For Untreated Liver Cancer Patients
March 07, 2025
From Benzinga
Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal
March 05, 2025
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 27, 2025
From Benzinga
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
February 26, 2025
From Motley Fool
Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review
February 24, 2025
From Benzinga
Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?
February 21, 2025
From Benzinga
Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer
February 19, 2025
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
February 19, 2025
From Benzinga
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
From Benzinga
Nuclear Power Is Solving the World’s Looming Energy Crisis
February 16, 2025
Tickers
BMY
From InvestorPlace
My “Two-Step” Plan for Surviving Shaky Markets – and Coming Out Ahead
February 15, 2025
Tickers
BMY
From InvestorPlace
How to Read Trump’s Tariff Playbook – and Prepare for His Next Moves
February 13, 2025
Tickers
BMY
From InvestorPlace
What's Going On With Bristol Myers Squibb Stock On Monday?
February 10, 2025
From Benzinga
US Stocks Likely To Open On A Mixed Note: Amazon, Pinterest, Take-Two Among Stocks To Watch
February 07, 2025
From Benzinga
S&P 500 Gains For 3rd Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
February 07, 2025
From Benzinga
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
February 06, 2025
From Benzinga
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
February 06, 2025
Tickers
BMY
From Motley Fool
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook
February 06, 2025
From Benzinga
Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts
February 06, 2025
From Benzinga
US Stocks Likely To Open Higher Ahead Of Amazon's Earnings: 'Buy The Dip' Mentality Remains Prevalent, Says Analyst
February 06, 2025
From Benzinga
Earnings Scheduled For February 6, 2025
February 06, 2025
From Benzinga
Dow Rises Over 300 Points As Nvidia Surges: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
February 06, 2025
From Benzinga
Bristol-Myers Squibb, Amazon And 3 Stocks To Watch Heading Into Thursday
February 06, 2025
From Benzinga
McDonald's To $290? Here Are 10 Top Analyst Forecasts For Tuesday
February 04, 2025
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
February 04, 2025
From Benzinga
2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond
February 03, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.